LakeShore Biopharma Co Performance
| LSBDelisted Stock | 0.63 0.00 0.00% |
The company secures a Beta (Market Risk) of -0.87, which conveys possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning LakeShore Biopharma are expected to decrease slowly. On the other hand, during market turmoil, LakeShore Biopharma is expected to outperform it slightly. At this point, LakeShore Biopharma has a negative expected return of -0.61%. Please make sure to verify LakeShore Biopharma's variance, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if LakeShore Biopharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days LakeShore Biopharma Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 246.6 M | |
| Total Cashflows From Investing Activities | -17 M |
LakeShore |
LakeShore Biopharma Relative Risk vs. Return Landscape
If you would invest 73.00 in LakeShore Biopharma Co on November 1, 2025 and sell it today you would lose (10.00) from holding LakeShore Biopharma Co or give up 13.7% of portfolio value over 90 days. LakeShore Biopharma Co is generating negative expected returns assuming volatility of 6.9762% on return distribution over 90 days investment horizon. In other words, 62% of stocks are less volatile than LakeShore, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
LakeShore Biopharma Target Price Odds to finish over Current Price
The tendency of LakeShore Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.63 | 90 days | 0.63 | close to 99 |
Based on a normal probability distribution, the odds of LakeShore Biopharma to move above the current price in 90 days from now is close to 99 (This LakeShore Biopharma Co probability density function shows the probability of LakeShore Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon LakeShore Biopharma Co has a beta of -0.87. This indicates Additionally LakeShore Biopharma Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. LakeShore Biopharma Price Density |
| Price |
Predictive Modules for LakeShore Biopharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LakeShore Biopharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LakeShore Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LakeShore Biopharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LakeShore Biopharma is not an exception. The market had few large corrections towards the LakeShore Biopharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LakeShore Biopharma Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LakeShore Biopharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.57 | |
β | Beta against Dow Jones | -0.87 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | -0.1 |
LakeShore Biopharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LakeShore Biopharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LakeShore Biopharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LakeShore Biopharma is not yet fully synchronised with the market data | |
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 614.96 M. Reported Net Loss for the year was (99.98 M) with profit before taxes, overhead, and interest of 507.19 M. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| About 88.0% of the company outstanding shares are owned by corporate insiders |
LakeShore Biopharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LakeShore Stock often depends not only on the future outlook of the current and potential LakeShore Biopharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LakeShore Biopharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 106.9 M | |
| Cash And Short Term Investments | 28.1 M |
LakeShore Biopharma Fundamentals Growth
LakeShore Stock prices reflect investors' perceptions of the future prospects and financial health of LakeShore Biopharma, and LakeShore Biopharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LakeShore Stock performance.
| Return On Equity | -0.18 | |||
| Return On Asset | -0.0215 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.69) % | |||
| Current Valuation | 88.96 M | |||
| Shares Outstanding | 41.21 M | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.04 X | |||
| Revenue | 614.96 M | |||
| EBITDA | (48.54 M) | |||
| Total Debt | 414.4 M | |||
| Book Value Per Share | 24.07 X | |||
| Cash Flow From Operations | (120.98 M) | |||
| Earnings Per Share | (0.73) X | |||
| Total Asset | 1.37 B | |||
| Retained Earnings | (2.41 B) | |||
About LakeShore Biopharma Performance
By analyzing LakeShore Biopharma's fundamental ratios, stakeholders can gain valuable insights into LakeShore Biopharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if LakeShore Biopharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if LakeShore Biopharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about LakeShore Biopharma performance evaluation
Checking the ongoing alerts about LakeShore Biopharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LakeShore Biopharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| LakeShore Biopharma is not yet fully synchronised with the market data | |
| LakeShore Biopharma generated a negative expected return over the last 90 days | |
| LakeShore Biopharma has high historical volatility and very poor performance | |
| LakeShore Biopharma has some characteristics of a very speculative penny stock | |
| LakeShore Biopharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the last year's revenue of 614.96 M. Reported Net Loss for the year was (99.98 M) with profit before taxes, overhead, and interest of 507.19 M. | |
| LakeShore Biopharma generates negative cash flow from operations | |
| About 88.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing LakeShore Biopharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LakeShore Biopharma's stock is overvalued or undervalued compared to its peers.
- Examining LakeShore Biopharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LakeShore Biopharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of LakeShore Biopharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LakeShore Biopharma's stock. These opinions can provide insight into LakeShore Biopharma's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in LakeShore Stock
If you are still planning to invest in LakeShore Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LakeShore Biopharma's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |